Guided Therapeutics (GTHP) Debt Ratio (2010 - 2025)
Guided Therapeutics (GTHP) reported Debt Ratio of 0.02 for Q4 2025, down 49.07% on a YoY basis from 0.03 in Q4 2024, and down 45.91% sequentially from 0.03 in Q3 2025.
Guided Therapeutics (GTHP) Debt Ratio (2010 - 2025) Analysis & Trends
Guided Therapeutics (GTHP) has 16 years of Debt Ratio data on file, last reported at 0.02 in Q4 2025.
- For the quarter ending Q4 2025, Debt Ratio fell 49.07% year-over-year to 0.02; the trailing twelve-month figure through Dec 2025 stood at 0.02 (down 49.07% YoY), and the FY2025 full-year result was 0.02, down 49.07% from the prior year.
- Debt Ratio declined to 0.02 in Q4 2025, from 0.03 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.95 in Q2 2024 to a low of 0.01 in Q1 2023.
- A 5-year average of 0.22 and a median of 0.05 in 2023 frame the typical range for Debt Ratio.
- Across the five-year window, Debt Ratio soared 1788.24% in 2024 and slumped 96.61% in 2025, its largest moves.
- Tracing GTHP's Debt Ratio over 5 years: stood at 0.33 in 2021, then sank by 93.44% to 0.02 in 2022, then soared by 129.5% to 0.05 in 2023, then tumbled by 32.0% to 0.03 in 2024, then sank by 49.07% to 0.02 in 2025.
- Business Quant data shows GTHP's Debt Ratio at 0.02 in Q4 2025, 0.03 in Q3 2025, and 0.04 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.31 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.30 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.25 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.04 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.30 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.27 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 0.30 |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 | 0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.02 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.04 |
| Mar 31, 2025 | 0.04 |
| Dec 31, 2024 | 0.03 |
| Sep 30, 2024 | 0.95 |
| Jun 30, 2024 | 0.95 |
| Mar 31, 2024 | 0.02 |
| Sep 30, 2023 | 0.05 |
| Jun 30, 2023 | 0.24 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.28 |
| Jun 30, 2022 | 0.05 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.33 |
| Sep 30, 2021 | 0.46 |
| Jun 30, 2021 | 0.43 |
| Mar 31, 2021 | 0.26 |
| Dec 31, 2020 | 0.26 |